## **Core Concept**
Beta blockers are a class of medications commonly used to manage cardiovascular conditions such as hypertension, angina, and certain arrhythmias. They work by blocking the effects of the hormone epinephrine, also known as adrenaline, and by slowing the heart rate and reducing its workload. In the context of renal failure, the choice of beta blocker is crucial because some beta blockers are metabolized or excreted by the kidneys, which can lead to accumulation and increased risk of side effects.

## **Why the Correct Answer is Right**
The correct answer, , is primarily metabolized by the liver, but its active metabolite is excreted by the kidneys. However, among the given options, is notably hydrophilic (water-soluble), which means it is primarily excreted unchanged by the kidneys. This characteristic makes it less suitable for use in patients with renal failure because it can accumulate to toxic levels.

## **Why Each Wrong Option is Incorrect**
* **Option A:** is lipophilic (fat-soluble) and primarily metabolized by the liver, making it suitable for use in renal failure.
* **Option B:** is also metabolized by the liver and has a pharmacokinetic profile that allows its use in patients with renal impairment.
* **Option C:** is another beta blocker that is metabolized by the liver, making it a safer choice for patients with renal failure.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that in patients with renal failure, it is generally safer to use beta blockers that are primarily metabolized by the liver rather than those excreted by the kidneys. This helps in minimizing the risk of drug accumulation and associated side effects.

## **Correct Answer:** . Propranolol